{"cluster": 38, "subcluster": 9, "abstract_summ": "The most common management strategy is the modification of immunosuppression along with current experimental strategies for COVID-19.SARS-CoV-2 in hematopoietic cell transplant (HCT) recipients is associated with severe coronavirus disease-2019 (COVID-19) and higher mortality.In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patients are getting infected and starting to develop coronavirus disease 2019 (COVID-19).Covid\u201019 disease is caused by a novel SARS\u2010CoV\u20102 virus and has been declared a pandemic on the 9(th) of March by WHO.A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community.In highly prevalent regions, stepwise evaluation, and management, as in the pre-COVID era, risks false-negatives and delay in therapy for COVID-19.An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions.", "title_summ": "Coronavirus Disease 2019 (COVID-19) in a Renal Transplant PatientDiagnostic considerations for COVID-19 in recipients of allogeneic hematopoietic cell transplantationCOVID\u201019 in kidney transplant recipientsCovid\u201019 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre ExperienceSuccessful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.", "title_abstract_phrases": "The most common management strategy is the modification of immunosuppression along with current experimental strategies for COVID-19.Diagnostic considerations for COVID-19 in recipients of allogeneic hematopoietic cell transplantationSARS-CoV-2 in hematopoietic cell transplant (HCT) recipients is associated with severe coronavirus disease-2019 (COVID-19) and higher mortality.In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patients are getting infected and starting to develop coronavirus disease 2019 (COVID-19).Covid\u201019 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre ExperienceCovid\u201019 disease is caused by a novel SARS\u2010CoV\u20102 virus and has been declared a pandemic on the 9(th) of March by WHO.A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.In highly prevalent regions, stepwise evaluation, and management, as in the pre-COVID era, risks false-negatives and delay in therapy for COVID-19.COVID\u201019 in kidney transplant recipientsAn outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions."}